Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Mesa Laboratories (MLAB) EPS (Weighted Average and Diluted) (2016 - 2025)

Mesa Laboratories' EPS (Weighted Average and Diluted) history spans 16 years, with the latest figure at $0.65 for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 309.68% to $0.65 in Q4 2025 year-over-year; TTM through Dec 2025 was $0.65, a 101.4% increase, with the full-year FY2025 number at -$0.36, up 99.24% from a year prior.
  • EPS (Weighted Average and Diluted) hit $0.65 in Q4 2025 for Mesa Laboratories, up from $0.45 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for MLAB hit a ceiling of $0.85 in Q2 2025 and a floor of -$47.26 in Q1 2024.
  • Historically, EPS (Weighted Average and Diluted) has averaged -$2.22 across 5 years, with a median of $0.18 in 2023.
  • The widest YoY moves for EPS (Weighted Average and Diluted): up 720.0% in 2024, down 43063.64% in 2024.
  • Tracing MLAB's EPS (Weighted Average and Diluted) over 5 years: stood at -$0.39 in 2021, then soared by 120.51% to $0.08 in 2022, then soared by 387.5% to $0.39 in 2023, then plummeted by 179.49% to -$0.31 in 2024, then surged by 309.68% to $0.65 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for MLAB at $0.65 in Q4 2025, $0.45 in Q3 2025, and $0.85 in Q2 2025.